The development of nuclear physics, having been dramatized by the explosion of several atomic bombs, has impressed everyone with the importance of radioactivity and the ionizing radiations. Physicians have watched these developments with much concern, anxious lest unexpected damage result from exposure to new kinds of rays and eager to use new diagnostic and therapeutic methods should these be forthcoming.
It is easy to become so preoccupied with developments in the physical aspects of this work that sight is lost of the equally important chemical and industrial aspects. This is forcibly brought to mind by recent volumes of the National Nuclear Energy Series, particularly the two books on the pharmacology and toxicology of uranium compounds, edited by Carl Voegtlin1 and reviewed in The Journal.2 The books of this series follow the best traditions of the modern "unclear" physics, in that their pages bristle with the signs and symbols
URANIUM AND FLUORINE. JAMA. 1950;143(12):1070-1071. doi:10.1001/jama.1950.02910470030012